Gail Y Higgins
Overview
Explore the profile of Gail Y Higgins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung E, Palmer S, Natale P, Krishnan A, Cooper T, Saglimbene V, et al.
Am J Kidney Dis
. 2021 Aug;
78(6):804-815.
PMID: 34364906
Rationale & Objective: Coronavirus disease 2019 (COVID-19) disproportionately affects people with chronic diseases such as chronic kidney disease (CKD). We assessed the incidence and outcomes of COVID-19 in people with...
2.
McGee R, Su M, Kelly P, Higgins G, Craig J, Webster A
Transplantation
. 2011 Oct;
92(10):1094-100.
PMID: 21978995
Background: Trial registration was introduced to reduce research bias by promoting trial transparency and accountability. We aimed to evaluate the frequency of, and factors associated with, trial registration and declaration...
3.
Brooks R, Higgins G, Webster A
Pediatr Nephrol
. 2010 Aug;
25(12):2383-92.
PMID: 20694479
Limited pediatric-specific research can lead to sub-standard evidence for clinical decision making in children. We sought to systematically evaluate the methodological quality and the reporting standards of randomized controlled trials...
4.
Webster A, Ruster L, McGee R, Matheson S, Higgins G, Willis N, et al.
Cochrane Database Syst Rev
. 2010 Jan;
(1):CD003897.
PMID: 20091551
Background: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but...